News
Form 8.3 - Maitland Institutional Services Limited: Re VP plc
Form 8.3 - Maitland Institutional Services Limited: Re Ideagen plc
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Aroundtown SA: Release of a capital market information
DGAP-Adhoc: Manz AG resolves cash capital increase without subscription rights in the amount of approximately 10 % of the share capital in the context of a cooperation agreement with Daimler Truck AG
DGAP-News: CLIQ Digital partners with Sportdigital for more live sports content
DGAP-News: bet-at-home.com AG: Group figures for the first quarter of 2022
DGAP-News: M1 Kliniken AG announces financials for Q1-2022: further growth of Beauty segment; ongoing optimisation of Trade segment
Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has signed an agreement to acquire EYSUVIS® (loteprednol etabonate suspension)
DGAP-News: beaconsmind AG strengthens sales team and lays foundation for further expansion in India and Saudi Arabia
Nicox (COX): Eye health portfolio targets large markets
DGAP-News: Marinomed Biotech AG reports strong 1st quarter 2022: continued growth trajectory for Carragelose
DGAP-Adhoc: Siemens Energy AG: Voluntary cash tender offer for outstanding shares in Siemens Gamesa Renewable Energy, S.A.
TriCo Bancshares Announces Quarterly Cash Dividend
The Board of Directors of TriCo Bancshares (NASDAQ: TCBK) (the “Company”), parent company of Tri Counties Bank, declared a quarterly cash dividend of $0.25 (twenty-five cents) per share on its
Albany International Declares Dividend
The Board of Directors of Albany International Corp. (NYSE: AIN) today declared a quarterly dividend of $0.21 per share on the Company’s Class A Common Stock, payable July 8, 2022, to shareholders
Aurinia Presents Results from the Two-Year AURORA 2 Continuation Study at the 2022 European Renal Association (ERA) Congress
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (Aurinia or the Company), a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, today presented
Magnit notifies JPMorgan Chase Bank, N.A. of termination of the deposit agreement and GDR programme
Alina Holdings PLC: Appointment of Non-Executive Director
Rights and Issues Investment Trust PLC: Transaction in Own Shares
DGAP-News: Allterco JSCo convenes Ordinary General Meeting of Shareholders